FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/092570 [Registered on: 07/08/2025] Trial Registered Prospectively
Last Modified On: 06/08/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Single Arm Study 
Public Title of Study   Assessment of associations of people with pimples over face 
Scientific Title of Study   Evaluating associations and metabolic parameters in adult acne and exploration of deep learning techniques for acne grading: A cross-sectional study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ishita Bansal 
Designation  Junior Resident, Department of Dermatology Venereology and Leprosy 
Affiliation  Kasturba Medical College, MAHE, Manipal 
Address  OPD 21, Old building, Department of Dermatology Venereology and Leprosy, Kasturba Medical College, Eshwar Nagar, Manipal, Karnataka

Udupi
KARNATAKA
576104
India 
Phone  9711942808  
Fax    
Email  ishib99@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ishita Bansal 
Designation  Junior Resident, Department of Dermatology Venereology and Leprosy 
Affiliation  Kasturba Medical College, MAHE, Manipal 
Address  OPD 21,Old building, Department of Dermatology Venereology and Leprosy, Kasturba Medical College, Eshwar Nagar, Manipal, Karnataka

Udupi
KARNATAKA
576104
India 
Phone  9711942808  
Fax    
Email  ishib99@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Ishita Bansal 
Designation  Junior Resident, Department of Dermatology Venereology and Leprosy 
Affiliation  Kasturba Medical College, MAHE, Manipal 
Address  OPD 21,Old building, Department of Dermatology Venereology and Leprosy, Kasturba Medical College, Eshwar Nagar, Manipal, Karnataka

Udupi
KARNATAKA
576104
India 
Phone  9711942808  
Fax    
Email  ishib99@gmail.com  
 
Source of Monetary or Material Support  
Department of Dermatology Venereology and Leprosy, Kasturba Medical College, Eshwar Nagar, Manipal, Karnataka 
 
Primary Sponsor  
Name  Dr Ishita Bansal 
Address  Department of Dermatology Venereology and Leprosy, KMC , Eshwar Nagar, Manipal, Karnataka, 576104 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ishita Bansal  Kasturba Medical College  OPD 21, Old building, Department of Dermatology Venereology and Leprosy, Kasturba Medical College, Eshwar Nagar, Manipal, Karnataka
Udupi
KARNATAKA 
9711942808

ishib99@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Kasturba Medical College and Kasturba Hospital Institutional Ethics Committee - 2 (Student Research)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: L700||Acne vulgaris,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  55.00 Year(s)
Gender  Both 
Details  All consulting adult patients of age more than 25 years of Acne vulgaris, who visit the dermatology outpatient/inpatient department at KMC, Manipal 
 
ExclusionCriteria 
Details  1)Clinical diagnosis of rosacea which can mimic acne
2)Acneiform eruptions
3)Drug induced acne
4)Truncal acne without any face lesions 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1. To study the clinical types and associations of adult acne
2. To grade acne based on modified Global Acne Grading System 
Baseline 
 
Secondary Outcome  
Outcome  TimePoints 
1. To integrate Artificial intelligence methods of machine learning / deep learning in acne grading
2. To correlate acne with visceral adiposity index and Insulin resistance in a subset of
study subjects 
2 years 
 
Target Sample Size   Total Sample Size="150"
Sample Size from India="150" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   18/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Prevalence and Impact: Acne affects approximately 9.4% of the global population, with

adolescents constituting about 85% of cases. It carries significant physical, psychological, and social burdens, straining the healthcare resources.

Epidemiological evidence shows a strong correlation between Insulin resistance and moderate to severe acne. Acne is more prevalent in metabolic disorders such as PCOS and metabolic syndrome, suggesting a role for metabolic dysfunction in its pathogenesis.

Therapeutic Implications: Early identification and management of metabolic abnormalities may enhance overall patient outcomes. Targeting insulin sensitivity (e.g., with metformin or dietary changes) could serve as an effective adjunct to traditional acne treatments.

Role of Artificial Intelligence (AI): AI can ensures objective, standardized, and reproducible acne grading, reducing the variability of traditional assessments. AI-driven models offer fast,

accurate, and personalized treatment recommendations and improve accessibility to

dermatological care, particularly in remote areas.

 
Close